Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jan;138(1):119-28.

Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma

Affiliations

Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma

R B Nagle et al. Am J Pathol. 1991 Jan.

Abstract

Thirty-one snap-frozen human prostate specimens containing examples of benign hyperplasia, prostatic intraepithelial neoplasia (PIN), and invasive carcinoma were analyzed using a panel of 24 antibodies and one lectin. Twenty-seven additional routinely processed radical prostatectomy specimens were studied using selected probes known to work on formalin-fixed paraffin-embedded material. Three probes, anticytokeratin KA4, anti-vimentin V9, and the lectin from Ulex europaeus (UEA-1), demonstrated phenotypic similarities between PIN and invasive carcinoma. Whereas the luminal cells of normal or hyperplastic prostatic epithelium are minimally reactive with KA4 (4%) or UEA-1 (0%) and strongly reactive with anti-vimentin (91%), both the PIN and invasive carcinoma are reactive with KA4 (89% and 93%, respectively) and UEA-1 (96% and 93%, respectively) and minimally reactive with anti-vimentin (15% and 0%, respectively). The increased KA4 staining was shown to be in part due to detection of cytokeratin 19, by using cytokeratin-19-specific antibodies, 4.62 and LP2K. The reasons for the increased expression of this cytokeratin and the decreased expression of vimentin are unclear but seem to indicate a phenotypic relationship between the PIN lesions and invasive carcinoma.

PubMed Disclaimer

References

    1. Prostate. 1988;12(1):47-53 - PubMed
    1. Cancer Res. 1985 Aug;45(8):3663-7 - PubMed
    1. J Histochem Cytochem. 1981 Apr;29(4):577-80 - PubMed
    1. Scand J Urol Nephrol. 1971;5(1):17-21 - PubMed
    1. Pathol Res Pract. 1980 Nov;169(3-4):366-87 - PubMed

Publication types

LinkOut - more resources